erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Nicola FG et al. Characterization of erythromycin-resistant isolates of Staphylococcus aureus recovered in the United States from 1958 through 1969. 1998 Antimicrob. Agents Chemother. pmid:9797248
Schneider SC et al. Antibiotic Susceptibility and Sequence Type Distribution of Ureaplasma Species Isolated from Genital Samples in Switzerland. 2015 Antimicrob. Agents Chemother. pmid:26195516
LeBlanc DJ et al. Broad geographical distribution of homologous erythromycin, kanamycin, and streptomycin resistance determinants among group D streptococci of human and animal origin. 1986 Antimicrob. Agents Chemother. pmid:3010845
Clewell DB and Franke AE Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes. 1974 Antimicrob. Agents Chemother. pmid:4618462
Ríos AM et al. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection. 2004 Antimicrob. Agents Chemother. pmid:15273098
Wagner J et al. Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline. 2003 Antimicrob. Agents Chemother. pmid:12821499
Kresken M et al. High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin. 2004 Antimicrob. Agents Chemother. pmid:15273149
Katz KC et al. Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. 2003 Antimicrob. Agents Chemother. pmid:12821502
Lee H et al. Isolation of antibiotic hypersusceptibility mutants of Acinetobacter spp. by selection for DNA release. 2003 Antimicrob. Agents Chemother. pmid:12654657
Donowitz GR and Earnhardt KI Azithromycin inhibition of intracellular Legionella micdadei. 1993 Antimicrob. Agents Chemother. pmid:8285604
Mingoia M et al. Heterogeneity of Tn5253-like composite elements in clinical Streptococcus pneumoniae isolates. 2011 Antimicrob. Agents Chemother. pmid:21263055
Grivea IN et al. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. 2006 Antimicrob. Agents Chemother. pmid:16377695
Martin JR et al. Uptake, accumulation, and egress of erythromycin by tissue culture cells of human origin. 1985 Antimicrob. Agents Chemother. pmid:3994346
Waites KB et al. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. 1988 Antimicrob. Agents Chemother. pmid:2973283
Nielsen EI et al. Pharmacokinetic/pharmacodynamic (PK/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization. 2011 Antimicrob. Agents Chemother. pmid:21807983
Del Grosso M et al. Tn2009, a Tn916-like element containing mef(E) in Streptococcus pneumoniae. 2004 Antimicrob. Agents Chemother. pmid:15155196
Song JH et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). 2004 Antimicrob. Agents Chemother. pmid:15155207
Nagata T et al. Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. 2004 Antimicrob. Agents Chemother. pmid:15155229
Novotny GW et al. Ketolide antimicrobial activity persists after disruption of interactions with domain II of 23S rRNA. 2004 Antimicrob. Agents Chemother. pmid:15388419
Nahata MC et al. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. 1993 Antimicrob. Agents Chemother. pmid:8383944
Villedieu A et al. Genetic basis of erythromycin resistance in oral bacteria. 2004 Antimicrob. Agents Chemother. pmid:15155239
Wüst J and Hardegger U Transferable resistance to clindamycin, erythromycin, and tetracycline in Clostridium difficile. 1983 Antimicrob. Agents Chemother. pmid:6870225
Gladue RP and Snider ME Intracellular accumulation of azithromycin by cultured human fibroblasts. 1990 Antimicrob. Agents Chemother. pmid:2168141
Unkles SE and Gemmell CG Effect of clindamycin, erythromycin, lincomycin, and tetracycline on growth and extracellular lipase production by propionibacteria in vitro. 1982 Antimicrob. Agents Chemother. pmid:7081974
Giovanetti E et al. A novel efflux system in inducibly erythromycin-resistant strains of Streptococcus pyogenes. 2002 Antimicrob. Agents Chemother. pmid:12435672
Reeves AR et al. Analysis of an 8.1-kb DNA fragment contiguous with the erythromycin gene cluster of Saccharopolyspora erythraea in the eryCI-flanking region. 2002 Antimicrob. Agents Chemother. pmid:12435693
Pestka S Antibiotics as probes of ribosome structure: binding of chloramphenicol and erythromycin to polyribosomes; effect of other antibiotics. 1974 Antimicrob. Agents Chemother. pmid:4599122
Finland M et al. Synergistic action of ampicillin and erythromycin against Nocardia asteroides: effect of time of incubation. 1974 Antimicrob. Agents Chemother. pmid:4599860
Akshay S et al. Phylogenetic sequence variations in bacterial rRNA affect species-specific susceptibility to drugs targeting protein synthesis. 2011 Antimicrob. Agents Chemother. pmid:21730122
Tateda K et al. Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. 1996 Antimicrob. Agents Chemother. pmid:8891128
Hunt Gerardo S et al. Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides. 1996 Antimicrob. Agents Chemother. pmid:8891154
Pannu J et al. In vitro antibacterial activity of NB-003 against Propionibacterium acnes. 2011 Antimicrob. Agents Chemother. pmid:21746943
Descours G et al. Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila. 2017 Antimicrob. Agents Chemother. pmid:28069647
Brandt-Rauf P et al. Fluorescent assay for estimating the binding of erythromycin derivatives to ribosomes. 1978 Antimicrob. Agents Chemother. pmid:356727
Kohno Y et al. Comparative pharmacokinetics of clarithromycin (TE-031), a new macrolide antibiotic, and erythromycin in rats. 1989 Antimicrob. Agents Chemother. pmid:2526615
Xin D et al. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China. 2009 Antimicrob. Agents Chemother. pmid:19273685
Wierzbowski AK et al. Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. 2005 Antimicrob. Agents Chemother. pmid:16251306
Zhou Z et al. Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China. 2015 Antimicrob. Agents Chemother. pmid:25451048
Betriu C et al. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance. 2004 Antimicrob. Agents Chemother. pmid:14693558
Hunfeld KP et al. Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. 2004 Antimicrob. Agents Chemother. pmid:14693564
Golparian D et al. In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? 2012 Antimicrob. Agents Chemother. pmid:22354296
Rouse MS et al. Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. 1997 Antimicrob. Agents Chemother. pmid:9257739
Green M et al. Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania. 2004 Antimicrob. Agents Chemother. pmid:14742197
Fuursted K Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension. 1997 Antimicrob. Agents Chemother. pmid:9257743
Jorgensen JH et al. Activities of cethromycin and telithromycin against recent North American isolates of Streptococcus pneumoniae. 2004 Antimicrob. Agents Chemother. pmid:14742216
Tissi L et al. In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G. 1995 Antimicrob. Agents Chemother. pmid:8540695
Simor AE et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals. 2007 Antimicrob. Agents Chemother. pmid:17724154
Rice LB et al. Tn5384, a composite enterococcal mobile element conferring resistance to erythromycin and gentamicin whose ends are directly repeated copies of IS256. 1995 Antimicrob. Agents Chemother. pmid:7625803
Cinco M et al. In vitro activity of rokitamycin, a new macrolide, against Borrelia burgdorferi. 1995 Antimicrob. Agents Chemother. pmid:7625812
Nagano N et al. Genetic heterogeneity in pbp genes among clinically isolated group B Streptococci with reduced penicillin susceptibility. 2008 Antimicrob. Agents Chemother. pmid:18809936
Dörries K et al. Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus. 2014 Antimicrob. Agents Chemother. pmid:25224006
Gentry DR et al. Genetic characterization of Vga ABC proteins conferring reduced susceptibility to pleuromutilins in Staphylococcus aureus. 2008 Antimicrob. Agents Chemother. pmid:18838584
Gaudreau C et al. Comparison of disk diffusion and agar dilution methods for erythromycin, ciprofloxacin, and tetracycline susceptibility testing of Campylobacter coli and for tetracycline susceptibility testing of Campylobacter jejuni subsp. jejuni. 2008 Antimicrob. Agents Chemother. pmid:18838597
Pérez-Trallero E et al. Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007). 2010 Antimicrob. Agents Chemother. pmid:20439616
Pendland SL et al. In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori. 2000 Antimicrob. Agents Chemother. pmid:10952605
Goldstein EJ et al. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections. 2000 Antimicrob. Agents Chemother. pmid:10952607
Bebear CM et al. In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized. 2000 Antimicrob. Agents Chemother. pmid:10952617
Cohn JR et al. In vitro antagonism by erythromycin of the bactericidal action of antimicrobial agents against common respiratory pathogens. 1980 Antimicrob. Agents Chemother. pmid:7235675
Bowie WR In vitro activity of rosaramicin against Chlamydia trachomatis. 1980 Antimicrob. Agents Chemother. pmid:7235684
Kouvela EC et al. Distinct mode of interaction of a novel ketolide antibiotic that displays enhanced antimicrobial activity. 2009 Antimicrob. Agents Chemother. pmid:19164155
Hao H et al. Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni. 2013 Antimicrob. Agents Chemother. pmid:23274667
Min YH et al. Translational attenuation and mRNA stabilization as mechanisms of erm(B) induction by erythromycin. 2008 Antimicrob. Agents Chemother. pmid:18299414
Hernould M et al. Role of the AheABC efflux pump in Aeromonas hydrophila intrinsic multidrug resistance. 2008 Antimicrob. Agents Chemother. pmid:18268083
Ralph ED and Amatnieks YE Potentially synergistic antimicrobial combinations with metronidazole against Bacteroides fragilis. 1980 Antimicrob. Agents Chemother. pmid:6448574
Benoni G et al. Pharmacokinetics and human tissue penetration of flurithromycin. 1988 Antimicrob. Agents Chemother. pmid:3245699
Yajko DM et al. Broth microdilution testing of susceptibilities to 30 antimicrobial agents of Mycobacterium avium strains from patients with acquired immune deficiency syndrome. 1987 Antimicrob. Agents Chemother. pmid:3501698
Stamm LV et al. In vitro assay to demonstrate high-level erythromycin resistance of a clinical isolate of Treponema pallidum. 1988 Antimicrob. Agents Chemother. pmid:3284454
Naik S and Ruck R In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex. 1989 Antimicrob. Agents Chemother. pmid:2817858
Williams MD et al. Early treatment of Campylobacter jejuni enteritis. 1989 Antimicrob. Agents Chemother. pmid:2818711
Swenson JM et al. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents. 1980 Antimicrob. Agents Chemother. pmid:6998374
Fass RJ Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. 1993 Antimicrob. Agents Chemother. pmid:8257127
Waites KB et al. Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas. 2008 Antimicrob. Agents Chemother. pmid:18663020
Wu JJ et al. High incidence of erythromycin-resistant streptococci in Taiwan. 1997 Antimicrob. Agents Chemother. pmid:9087502
Allen VG et al. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. 2011 Antimicrob. Agents Chemother. pmid:21098249
Urich SK and Petersen JM In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. 2008 Antimicrob. Agents Chemother. pmid:18411318
Laohavaleeson S et al. Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains. 2008 Antimicrob. Agents Chemother. pmid:18411322
Hsieh YC et al. Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan. 2008 Antimicrob. Agents Chemother. pmid:18413298
Liu Y et al. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. 2009 Antimicrob. Agents Chemother. pmid:19029328
Siibak T et al. Erythromycin- and chloramphenicol-induced ribosomal assembly defects are secondary effects of protein synthesis inhibition. 2009 Antimicrob. Agents Chemother. pmid:19029332
Chan YY et al. Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei. 2007 Antimicrob. Agents Chemother. pmid:17145801
Rakita RM et al. Intracellular activity of azithromycin against bacterial enteric pathogens. 1994 Antimicrob. Agents Chemother. pmid:7810998
Pankuch GA et al. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. 1994 Antimicrob. Agents Chemother. pmid:7811020
Yazawa K et al. Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species. 1994 Antimicrob. Agents Chemother. pmid:7811046
Segreti J and Kapell KS In vitro activity of dirithromycin against Chlamydia trachomatis. 1994 Antimicrob. Agents Chemother. pmid:7811051
Michel J et al. Effects of subminimal inhibitory concentrations of Erythromycin, Clindamycin, and Pristinamycin on the penicillinase production of Staphlyococcus aureus. 1980 Antimicrob. Agents Chemother. pmid:6965441
Ritz N et al. Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics. 2009 Antimicrob. Agents Chemother. pmid:18955515
Brummett RE and Fox KE Vancomycin- and erythromycin-induced hearing loss in humans. 1989 Antimicrob. Agents Chemother. pmid:2669623
Hölzel CS et al. Resistance to linezolid in a porcine Clostridium perfringens strain carrying a mutation in the rplD gene encoding the ribosomal protein L4. 2010 Antimicrob. Agents Chemother. pmid:20065060
Gygax SE et al. Erythromycin and clindamycin resistance in group B streptococcal clinical isolates. 2006 Antimicrob. Agents Chemother. pmid:16641466
Casal J Antimicrobial susceptibility of Streptococcus pneumoniae: serotype distribution of penicillin-resistant strains in Spain. 1982 Antimicrob. Agents Chemother. pmid:6927283
Dowling JN et al. Bactericidal activity of antibiotics against Legionella micdadei (Pittsburgh pneumonia agent). 1982 Antimicrob. Agents Chemother. pmid:6927637
Giovanetti E et al. ICESp2905, the erm(TR)-tet(O) element of Streptococcus pyogenes, is formed by two independent integrative and conjugative elements. 2012 Antimicrob. Agents Chemother. pmid:21986826
Hu WS et al. Outer membrane protein STM3031 (Ail/OmpX-like protein) plays a key role in the ceftriaxone resistance of Salmonella enterica serovar Typhimurium. 2009 Antimicrob. Agents Chemother. pmid:19470505
Kuo MS et al. Microbial glycosylation of erythromycin A. 1989 Antimicrob. Agents Chemother. pmid:2619274
Simor AE et al. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. 1989 Antimicrob. Agents Chemother. pmid:2712542
Neuhauser MM et al. Postantibiotic effects of ABT-773 and amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. 2001 Antimicrob. Agents Chemother. pmid:11709352
Singh KV et al. In vitro activities of a new ketolide, ABT-773, against multidrug-resistant gram-positive cocci. 2001 Antimicrob. Agents Chemother. pmid:11709359
Muto Y et al. Macrolide accumulation by Bacteroides fragilis ATCC 25285. 1989 Antimicrob. Agents Chemother. pmid:2719467
Chin NX and Neu HC In vitro activity of MC-352, a new 16-membered macrolide. 1992 Antimicrob. Agents Chemother. pmid:1416853
English AR et al. Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency. 1984 Antimicrob. Agents Chemother. pmid:6703675